Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain A, 2-oxoglutarate Oxygenase | 6 | 0 | 0 | 6 |
aldehyde dehydrogenase 1 family, member A1 | 7 | 0 | 0 | 7 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 5 | 0 | 9 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 4 | 0 | 8 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 4 | 0 | 8 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 4 | 0 | 8 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 1 | 2 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 4 | 0 | 8 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 4 | 0 | 8 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 4 | 0 | 8 |
estrogen nuclear receptor alpha | 13 | 0 | 0 | 13 |
Free fatty acid receptor 3 | 0 | 0 | 1 | 1 |
Free fatty acid receptor 2 | 0 | 1 | 1 | 2 |
Tyrosine-protein kinase Lck | 0 | 1 | 1 | 2 |
Tyrosine-protein kinase Fyn | 0 | 1 | 1 | 2 |
Fibrinogen C domain-containing protein 1 | 0 | 1 | 0 | 1 |
Chain A, Ferritin light chain | 3 | 0 | 0 | 3 |
phosphopantetheinyl transferase | 6 | 0 | 0 | 6 |
Bloom syndrome protein isoform 1 | 6 | 0 | 0 | 6 |
vitamin D3 receptor isoform VDRA | 1 | 0 | 0 | 1 |
DNA polymerase kappa isoform 1 | 4 | 0 | 0 | 4 |
Fatty-acid amide hydrolase 1 | 0 | 3 | 0 | 3 |
Fatty-acid amide hydrolase 1 | 0 | 0 | 0 | 1 |
Potassium channel subfamily K member 3 | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 2 | 0 | 0 | 2 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Glutamate receptor 1 | 0 | 0 | 1 | 1 |
Glutamate receptor 2 | 2 | 0 | 1 | 3 |
Glutamate receptor 3 | 0 | 0 | 1 | 1 |
Glutamate receptor 4 | 0 | 0 | 1 | 1 |
Cannabinoid receptor 1 | 0 | 1 | 1 | 2 |
Cannabinoid receptor 1 | 0 | 2 | 0 | 3 |
Cannabinoid receptor 2 | 0 | 2 | 0 | 3 |
Alpha-1A adrenergic receptor | 0 | 3 | 0 | 3 |
Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
Histamine H2 receptor | 3 | 1 | 1 | 6 |
Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
Fatty-acid amide hydrolase 1 | 0 | 4 | 0 | 5 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Corticotropin-releasing factor receptor 2 | 0 | 2 | 0 | 2 |
Lanosterol 14-alpha demethylase | 0 | 1 | 0 | 1 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 2 | 6 |
Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 1 | 2 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 5 | 0 | 0 | 5 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 2 | 0 | 0 | 2 |
Chain A, Phospholipase A2 isoform 3 | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 3 | 0 | 0 | 3 |
Chain B, HADH2 protein | 3 | 0 | 0 | 3 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
interleukin 8 | 1 | 0 | 0 | 1 |
thioredoxin reductase | 6 | 0 | 0 | 6 |
GLS protein | 8 | 0 | 0 | 8 |
AR protein | 9 | 0 | 0 | 9 |
thyroid stimulating hormone receptor | 4 | 0 | 0 | 4 |
hypothetical protein, conserved | 1 | 0 | 0 | 1 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 4 | 0 | 0 | 4 |
EWS/FLI fusion protein | 3 | 0 | 0 | 3 |
glucocorticoid receptor [Homo sapiens] | 5 | 0 | 0 | 5 |
retinoic acid nuclear receptor alpha variant 1 | 9 | 0 | 0 | 9 |
estrogen-related nuclear receptor alpha | 8 | 0 | 0 | 8 |
cytochrome P450 2D6 | 4 | 0 | 0 | 4 |
glucocerebrosidase | 2 | 0 | 0 | 2 |
peroxisome proliferator-activated receptor delta | 3 | 0 | 0 | 3 |
Rac1 protein | 0 | 0 | 1 | 1 |
IDH1 | 1 | 0 | 0 | 1 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
euchromatic histone-lysine N-methyltransferase 2 | 10 | 0 | 0 | 10 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 2 | 0 | 0 | 2 |
DNA polymerase iota isoform a (long) | 6 | 0 | 0 | 6 |
muscarinic acetylcholine receptor M1 | 6 | 0 | 0 | 6 |
lethal factor (plasmid) | 2 | 0 | 0 | 2 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
ATP-binding cassette sub-family C member 3 | 0 | 7 | 0 | 7 |
Multidrug resistance-associated protein 4 | 0 | 7 | 0 | 7 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Bile salt export pump | 0 | 13 | 0 | 13 |
Epidermal growth factor receptor | 0 | 2 | 0 | 2 |
Carbonic anhydrase 1 | 0 | 4 | 0 | 8 |
Carbonic anhydrase 2 | 0 | 4 | 0 | 9 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Integrin beta-3 | 1 | 1 | 0 | 2 |
Myeloperoxidase | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 2 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 1 | 0 | 1 |
Integrin alpha-IIb | 1 | 1 | 0 | 2 |
Glutathione hydrolase 1 proenzyme | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
Adenosine receptor A1 | 0 | 1 | 0 | 4 |
Adenosine receptor A2a | 0 | 1 | 0 | 4 |
Substance-P receptor | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 2 |
Urotensin-2 receptor | 0 | 1 | 0 | 1 |
4-aminobutyrate aminotransferase, mitochondrial | 0 | 1 | 0 | 1 |
Nuclear receptor ROR-gamma | 2 | 0 | 0 | 2 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 3 | 5 | 1 | 9 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
Canalicular multispecific organic anion transporter 1 | 0 | 7 | 0 | 7 |
Sigma non-opioid intracellular receptor 1 | 0 | 4 | 1 | 5 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 1 | 4 |
GLI family zinc finger 3 | 7 | 0 | 0 | 7 |
nuclear receptor subfamily 1, group I, member 3 | 4 | 0 | 0 | 4 |
retinoid X nuclear receptor alpha | 4 | 0 | 0 | 4 |
pregnane X nuclear receptor | 10 | 0 | 0 | 10 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
DNA polymerase beta | 1 | 0 | 0 | 1 |
short transient receptor potential channel 6 isoform 1 | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 1 | 0 | 5 | 0 | 6 |
5-hydroxytryptamine receptor 4 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M2 | 0 | 2 | 1 | 6 |
Muscarinic acetylcholine receptor M4 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M1 | 0 | 4 | 1 | 7 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 1 | 7 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 1 | 7 |
Muscarinic acetylcholine receptor M5 | 0 | 5 | 1 | 8 |
Muscarinic acetylcholine receptor M5 | 0 | 2 | 1 | 5 |
Muscarinic acetylcholine receptor M2 | 0 | 4 | 1 | 8 |
Muscarinic acetylcholine receptor M1 | 0 | 2 | 1 | 6 |
Muscarinic acetylcholine receptor M1 | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 2 | 1 | 5 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 5 | 0 | 5 |
Muscarinic acetylcholine receptor M4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
Reverse transcriptase/RNaseH | 0 | 0 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 1 | 2 |
regulator of G-protein signaling 4 | 4 | 0 | 0 | 4 |
histone acetyltransferase KAT2A isoform 1 | 2 | 0 | 0 | 2 |
15-lipoxygenase, partial | 2 | 0 | 0 | 2 |
RAR-related orphan receptor gamma | 7 | 0 | 0 | 7 |
TDP1 protein | 4 | 0 | 0 | 4 |
Microtubule-associated protein tau | 4 | 0 | 0 | 4 |
estrogen receptor 2 (ER beta) | 2 | 0 | 0 | 2 |
progesterone receptor | 5 | 0 | 0 | 5 |
67.9K protein | 1 | 0 | 0 | 1 |
peroxisome proliferator activated receptor gamma | 6 | 0 | 0 | 6 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 6 | 0 | 0 | 6 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 5 | 0 | 0 | 5 |
chromobox protein homolog 1 | 4 | 0 | 0 | 4 |
thyroid hormone receptor beta isoform 2 | 6 | 0 | 0 | 6 |
mitogen-activated protein kinase 1 | 1 | 0 | 0 | 1 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 7 | 0 | 0 | 7 |
nuclear receptor ROR-gamma isoform 1 | 3 | 0 | 0 | 3 |
peripheral myelin protein 22 | 6 | 0 | 0 | 6 |
survival motor neuron protein isoform d | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 3 | 0 | 0 | 3 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
lamin isoform A-delta10 | 10 | 0 | 0 | 10 |
Gamma-aminobutyric acid receptor subunit pi | 3 | 4 | 1 | 8 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 2 | 1 | 3 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 2 | 0 | 0 | 2 |
NADH-ubiquinone oxidoreductase chain 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 1A2 | 0 | 1 | 0 | 2 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 3 | 4 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit delta | 3 | 4 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 3 | 4 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 3 | 4 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 3 | 4 | 1 | 8 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 3 | 4 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 3 | 4 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 3 | 4 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 3 | 4 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 3 | 4 | 1 | 8 |
Spike glycoprotein | 4 | 0 | 0 | 4 |
D(2) dopamine receptor | 0 | 1 | 2 | 3 |
Gamma-aminobutyric acid receptor subunit beta-3 | 3 | 4 | 1 | 8 |
Gamma-aminobutyric acid receptor subunit beta-2 | 3 | 4 | 1 | 8 |
Inositol monophosphatase 1 | 2 | 0 | 0 | 2 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 1 | 0 | 1 |
GABA theta subunit | 3 | 4 | 1 | 8 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 3 | 4 | 1 | 8 |
ATP-dependent phosphofructokinase | 4 | 0 | 0 | 4 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 5 |
Carbonic anhydrase | 0 | 1 | 0 | 5 |
Carbonic anhydrase 15 | 0 | 1 | 0 | 5 |
Opioid receptor, delta 1b | 0 | 2 | 0 | 2 |
thyroid hormone receptor beta isoform a | 2 | 0 | 0 | 2 |
Opioid receptor homologue | 0 | 2 | 0 | 2 |
Proenkephalin-B | 0 | 0 | 1 | 1 |
Delta-type opioid receptor | 0 | 7 | 2 | 12 |
Delta-type opioid receptor | 0 | 7 | 3 | 11 |
Kappa-type opioid receptor | 0 | 4 | 1 | 7 |
Mu-type opioid receptor | 0 | 7 | 4 | 14 |
Kappa-type opioid receptor | 0 | 5 | 3 | 9 |
Mu-type opioid receptor | 0 | 8 | 4 | 14 |
Delta-type opioid receptor | 0 | 7 | 3 | 12 |
Kappa-type opioid receptor | 0 | 7 | 1 | 8 |
Kappa-type opioid receptor | 0 | 7 | 4 | 13 |
Mu-type opioid receptor | 0 | 5 | 1 | 9 |
Mu-type opioid receptor | 0 | 8 | 1 | 9 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Luciferase | 6 | 0 | 0 | 6 |
potassium voltage-gated channel subfamily H member 2 isoform d | 3 | 0 | 0 | 3 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
Amine oxidase [flavin-containing] A | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] B | 0 | 1 | 0 | 1 |
Histamine H1 receptor | 0 | 5 | 2 | 7 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 4 | 0 | 4 |
Sigma non-opioid intracellular receptor 1 | 0 | 3 | 0 | 3 |
hypoxia-inducible factor 1 alpha subunit | 3 | 0 | 0 | 3 |
Histone H2A.x | 3 | 0 | 0 | 3 |
Menin | 0 | 0 | 1 | 1 |
Lecithin retinol acyltransferase | 0 | 1 | 0 | 1 |
30S ribosomal protein S6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S7 | 0 | 1 | 0 | 1 |
50S ribosomal protein L15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L10 | 0 | 1 | 0 | 1 |
50S ribosomal protein L11 | 0 | 1 | 0 | 1 |
50S ribosomal protein L7/L12 | 0 | 1 | 0 | 1 |
50S ribosomal protein L19 | 0 | 1 | 0 | 1 |
50S ribosomal protein L1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L20 | 0 | 1 | 0 | 1 |
50S ribosomal protein L27 | 0 | 1 | 0 | 1 |
50S ribosomal protein L28 | 0 | 1 | 0 | 1 |
50S ribosomal protein L29 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 | 0 | 1 | 0 | 1 |
50S ribosomal protein L31 type B | 0 | 1 | 0 | 1 |
50S ribosomal protein L32 | 0 | 1 | 0 | 1 |
50S ribosomal protein L33 | 0 | 1 | 0 | 1 |
50S ribosomal protein L34 | 0 | 1 | 0 | 1 |
50S ribosomal protein L35 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 | 0 | 1 | 0 | 1 |
30S ribosomal protein S10 | 0 | 1 | 0 | 1 |
30S ribosomal protein S11 | 0 | 1 | 0 | 1 |
30S ribosomal protein S12 | 0 | 1 | 0 | 1 |
30S ribosomal protein S13 | 0 | 1 | 0 | 1 |
30S ribosomal protein S16 | 0 | 1 | 0 | 1 |
30S ribosomal protein S18 | 0 | 1 | 0 | 1 |
30S ribosomal protein S19 | 0 | 1 | 0 | 1 |
30S ribosomal protein S20 | 0 | 1 | 0 | 1 |
30S ribosomal protein S2 | 0 | 1 | 0 | 1 |
30S ribosomal protein S3 | 0 | 1 | 0 | 1 |
30S ribosomal protein S4 | 0 | 1 | 0 | 1 |
30S ribosomal protein S5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S8 | 0 | 1 | 0 | 1 |
30S ribosomal protein S9 | 0 | 1 | 0 | 1 |
50S ribosomal protein L13 | 0 | 1 | 0 | 1 |
50S ribosomal protein L14 | 0 | 1 | 0 | 1 |
50S ribosomal protein L16 | 0 | 1 | 0 | 1 |
50S ribosomal protein L23 | 0 | 1 | 0 | 1 |
30S ribosomal protein S15 | 0 | 1 | 0 | 1 |
50S ribosomal protein L17 | 0 | 1 | 0 | 1 |
50S ribosomal protein L21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L30 | 0 | 1 | 0 | 1 |
50S ribosomal protein L6 | 0 | 1 | 0 | 1 |
30S ribosomal protein S14 | 0 | 1 | 0 | 1 |
30S ribosomal protein S17 | 0 | 1 | 0 | 1 |
30S ribosomal protein S1 | 0 | 1 | 0 | 1 |
50S ribosomal protein L18 | 0 | 1 | 0 | 1 |
Lethal factor | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 1 | 0 | 1 |
50S ribosomal protein L3 | 0 | 1 | 0 | 1 |
50S ribosomal protein L24 | 0 | 1 | 0 | 1 |
50S ribosomal protein L4 | 0 | 1 | 0 | 1 |
50S ribosomal protein L22 | 0 | 1 | 0 | 1 |
50S ribosomal protein L5 | 0 | 1 | 0 | 1 |
30S ribosomal protein S21 | 0 | 1 | 0 | 1 |
50S ribosomal protein L25 | 0 | 1 | 0 | 1 |
50S ribosomal protein L36 2 | 0 | 1 | 0 | 1 |
Protein Rev | 0 | 0 | 1 | 1 |
Aminoglycoside 3'-phosphotransferase | 0 | 0 | 0 | 1 |
Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
Chain A, Beta-lactamase | 1 | 0 | 0 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
USP1 protein, partial | 4 | 0 | 0 | 4 |
GALC protein | 1 | 0 | 0 | 1 |
apical membrane antigen 1, AMA1 | 2 | 0 | 0 | 2 |
bromodomain adjacent to zinc finger domain 2B | 2 | 0 | 0 | 2 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 12 | 0 | 0 | 0 | 4 |
Solute carrier family 22 member 3 | 0 | 2 | 0 | 3 |
Plasma kallikrein | 0 | 0 | 0 | 4 |
Carbonic anhydrase 3 | 0 | 0 | 0 | 4 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Carbonic anhydrase 6 | 0 | 0 | 0 | 4 |
Histamine H2 receptor | 0 | 1 | 2 | 3 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 1 |
Histamine H1 receptor | 0 | 1 | 2 | 3 |
Histamine H1 receptor | 0 | 3 | 1 | 4 |
Metabotropic glutamate receptor 5 | 0 | 1 | 1 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 0 | 0 | 4 |
Carbonic anhydrase 7 | 0 | 0 | 0 | 4 |
Carbonic anhydrase | 0 | 0 | 0 | 5 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 9 | 0 | 0 | 0 | 4 |
Carbonic anhydrase | 0 | 0 | 0 | 5 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 4 |
Carbonic anhydrase | 0 | 0 | 0 | 5 |
Carbonic anhydrase | 0 | 0 | 0 | 5 |
Solute carrier family 22 member 1 | 0 | 2 | 0 | 3 |
Carbonic anhydrase | 0 | 0 | 0 | 5 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 0 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 0 | 0 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 14 | 0 | 0 | 0 | 4 |
Carbonic anhydrase 5B, mitochondrial | 0 | 0 | 0 | 4 |
Histamine H3 receptor | 0 | 1 | 2 | 3 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 2 | 0 | 0 | 2 |
ATAD5 protein, partial | 1 | 0 | 0 | 1 |
Thrombopoietin | 1 | 0 | 0 | 1 |
Parkin | 1 | 0 | 0 | 1 |
arylsulfatase A | 4 | 0 | 0 | 4 |
pyruvate kinase | 2 | 0 | 0 | 2 |
cytochrome P450 2D6 isoform 1 | 2 | 0 | 0 | 2 |
NPC intracellular cholesterol transporter 1 precursor | 1 | 0 | 0 | 1 |
cellular tumor antigen p53 isoform a | 1 | 0 | 0 | 1 |
ras-related protein Rab-9A | 1 | 0 | 0 | 1 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
N-glycosylase/DNA lyase | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
Aspartate aminotransferase, cytoplasmic | 0 | 1 | 0 | 1 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
Ataxin-2 | 2 | 0 | 0 | 2 |
Single-stranded DNA cytosine deaminase | 1 | 0 | 0 | 1 |
Snq2p | 0 | 0 | 0 | 1 |
activating transcription factor 6 | 3 | 0 | 0 | 3 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 2 | 0 | 0 | 2 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 4 | 0 | 0 | 4 |
D(1A) dopamine receptor | 2 | 0 | 0 | 2 |
atrial natriuretic peptide receptor 2 precursor | 1 | 0 | 0 | 1 |
serine/threonine-protein kinase mTOR isoform 1 | 1 | 0 | 0 | 1 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 2 | 0 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 2 | 0 | 2 |
Major prion protein | 0 | 0 | 1 | 1 |
Cellular tumor antigen p53 | 3 | 0 | 0 | 3 |
Cytochrome P450 3A4 | 0 | 2 | 1 | 4 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
Cytochrome P450 2D6 | 0 | 2 | 0 | 2 |
Cytochrome P450 2C9 | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Alpha-1B adrenergic receptor | 0 | 2 | 0 | 2 |
Sphingomyelin phosphodiesterase | 0 | 1 | 0 | 1 |
D | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1A | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A4 | 0 | 1 | 0 | 2 |
Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
Sodium-dependent noradrenaline transporter | 0 | 4 | 0 | 4 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
D(1B) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 1 | 0 | 1 |
D(4) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1F | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
Sodium-dependent serotonin transporter | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 0 | 0 | 1 |
Pleiotropic ABC efflux transporter of multiple drugs | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 5B | 0 | 1 | 0 | 1 |
Sodium channel protein type 1 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 4 subunit alpha | 0 | 3 | 0 | 4 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 1 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 6 | 0 | 1 | 0 | 1 |
Cytochrome P450 2J2 | 0 | 2 | 0 | 2 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
Voltage-dependent N-type calcium channel subunit alpha-1B | 0 | 1 | 0 | 1 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 2 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
Envelope glycoprotein | 0 | 0 | 1 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Sodium channel protein type 5 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 9 subunit alpha | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
Sodium-dependent dopamine transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 1 |
Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
Multidrug and toxin extrusion protein 1 | 0 | 2 | 0 | 2 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Transporter | 0 | 2 | 0 | 2 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
acetylcholinesterase | 2 | 0 | 0 | 2 |
aryl hydrocarbon receptor | 2 | 0 | 0 | 2 |
histone deacetylase 9 isoform 3 | 1 | 0 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit alpha-7 | 0 | 1 | 0 | 1 |
geminin | 4 | 0 | 0 | 4 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 1 |
Acetylcholinesterase | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 1 |
Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
Cholinesterase | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, AMINOPEPTIDASE | 0 | 1 | 0 | 1 |
Chain A, Leucine Aminopeptidase | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Intestinal-type alkaline phosphatase | 0 | 2 | 0 | 2 |
Large neutral amino acids transporter small subunit 1 | 0 | 4 | 0 | 4 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 3 |
Phospholipase A-2-activating protein | 0 | 2 | 0 | 2 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 1 | 0 | 0 | 1 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 1 | 0 | 0 | 1 |
dopamine D1 receptor | 1 | 0 | 0 | 1 |
WRN | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 3 | 0 | 0 | 3 |
hexokinase-4 isoform 1 | 1 | 0 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 2 | 0 | 0 | 2 |
glucokinase regulatory protein | 1 | 0 | 0 | 1 |
importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
flap endonuclease 1 | 3 | 0 | 0 | 3 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 1 | 0 | 0 | 1 |
snurportin-1 | 1 | 0 | 0 | 1 |
DNA polymerase eta isoform 1 | 1 | 0 | 0 | 1 |
M-phase phosphoprotein 8 | 2 | 0 | 0 | 2 |
Polyphenol oxidase 2 | 0 | 0 | 0 | 2 |
Tyrosinase | 0 | 1 | 0 | 1 |
Solute carrier family 15 member 1 | 0 | 1 | 0 | 1 |
SLC16A10 protein | 0 | 0 | 0 | 3 |
Monocarboxylate transporter 10 | 0 | 0 | 0 | 3 |
phosphoglycerate kinase | 1 | 0 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
Translocator protein | 0 | 1 | 1 | 2 |
UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 2B10 | 0 | 1 | 0 | 1 |
Acyl-CoA desaturase 1 | 0 | 1 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 1 | 1 |
Histidine decarboxylase | 0 | 0 | 2 | 2 |
Proteinase-activated receptor 1 | 0 | 1 | 1 | 2 |
Nociceptin receptor | 0 | 1 | 0 | 1 |
Mu-type opioid receptor | 0 | 1 | 0 | 1 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 2 | 2 |
Adenosine receptor A1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A8 | 0 | 0 | 0 | 2 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
endonuclease IV | 1 | 0 | 0 | 1 |
G | 2 | 0 | 0 | 2 |
peripheral myelin protein 22 isoform 1 | 2 | 0 | 0 | 2 |
cytochrome P450 2C9 precursor | 1 | 0 | 0 | 1 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 1 | 0 | 0 | 1 |
transcriptional regulator ERG isoform 3 | 1 | 0 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Dihydrofolate reductase | 0 | 1 | 0 | 1 |
Interferon beta | 2 | 0 | 0 | 2 |
HLA class I histocompatibility antigen, B alpha chain | 2 | 0 | 0 | 2 |
Sodium channel protein type 2 subunit alpha | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 2 | 1 | 3 |
Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 2 | 1 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 1 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Inositol hexakisphosphate kinase 1 | 2 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
cytochrome P450 2C9, partial | 2 | 0 | 0 | 2 |
Glutamate 5-kinase | 0 | 0 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
Amino acid transporter | 0 | 1 | 0 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 0 | 0 | 1 | 1 |
caspase 7, apoptosis-related cysteine protease | 1 | 0 | 0 | 1 |
farnesoid X nuclear receptor | 2 | 0 | 0 | 2 |
caspase-3 | 1 | 0 | 0 | 1 |
heat shock protein beta-1 | 2 | 0 | 0 | 2 |
UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 0 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 0 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 2 | 0 | 2 |
Caspase-7 | 1 | 0 | 0 | 1 |
caspase-3 | 1 | 0 | 0 | 1 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Substance-K receptor | 0 | 1 | 1 | 2 |
Substance-K receptor | 0 | 2 | 0 | 2 |
Substance-P receptor | 0 | 2 | 1 | 3 |
Neuromedin-K receptor | 0 | 1 | 1 | 2 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
Chain A, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain K, Trp Rna-binding Attenuation Protein | 0 | 0 | 1 | 1 |
Chain B, tryptophanyl-tRNA synthetase | 0 | 0 | 1 | 1 |
Chain C, Tryptophanyl-tRNA synthetase II | 0 | 0 | 1 | 1 |
thioredoxin glutathione reductase | 1 | 0 | 0 | 1 |
thyroid stimulating hormone receptor | 1 | 0 | 0 | 1 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 1 | 0 | 0 | 1 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
Stromelysin-1 | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 2 |
Tryptophan 2,3-dioxygenase | 0 | 1 | 0 | 2 |
Tryprostatin B synthase | 0 | 0 | 0 | 1 |
2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase | 0 | 0 | 1 | 1 |
Chain A, CHORISMATE MUTASE | 0 | 1 | 0 | 1 |
Chain A, TYROSYL-tRNA SYNTHETASE | 0 | 0 | 1 | 1 |
Tubulin--tyrosine ligase | 0 | 1 | 0 | 1 |
Taste receptor type 2 member 14 | 0 | 0 | 0 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Chain A, Glycogen phosphorylase, liver form | 0 | 0 | 1 | 1 |
Solute carrier family 22 member 6 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
Solute carrier family 2, facilitated glucose transporter member 9 | 0 | 1 | 1 | 2 |
Guanine deaminase | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |